Retatrutide is a triple agonist acting on GLP-1, GIP, and glucagon receptors, distinguishing it from approved agents such as semaglutide or tirzepatide
While gastrointestinal issues are common side effects, the biggest setbacks happen when the patient stops taking a GLP-1
This is mainly due to reduced stomach acid production and lower intrinsic factor levels, both of which impair vitamin absorption
Our program includes sophisticated body composition analysis and monitoring capabilities, utilizing state-of-the-art technology such as bioelectrical impedance analysis to accurately assess your body fat percentage, muscle mass, and metabolic rate, providing valuable insights into your progress and helping to fine-tune your treatment plan for optimal results
The abdomen typically offers the most predictable absorption